Search Contract Opportunities

Metaxalone Tablets   3

ID: SPE2D2-26-R-0001 • Type: Solicitation • Match:  100%
Opportunity Assistant

Hello! Please let me know your questions about this opportunity. I will answer based on the available opportunity documents.

Please sign-in to link federal registration and award history to assistant. Sign in to upload a capability statement or catalogue for your company

Popular Questions:
Generate a draft:

Description

Posted: Dec. 22, 2025, 10:52 a.m. EST

Solicitation Attached

Amendment 0003 added

Posted: Dec. 8, 2025, 1:12 p.m. EST
Posted: Nov. 12, 2025, 9:35 a.m. EST
Posted: Nov. 7, 2025, 9:58 a.m. EST
Background
The solicitation is issued by the Defense Logistics Agency (DLA) for the procurement of Metaxalone Tablets. The DLA's mission is to provide logistics support to the military and other federal agencies, ensuring that they have the necessary supplies and equipment to fulfill their missions. The goal of this contract is to supply Metaxalone Tablets, which are used as a muscle relaxant in the treatment of muscle pain and discomfort.

Work Details
The contract involves the delivery of Metaxalone 800 MG tablets in two different packaging sizes: 100 Count Bottles (BTL) and 500 Count Bottles (BTL). The estimated quantities for each item are as follows:

- Item No. 0001: Metaxalone 800 MG tablet – 100 Count BTL
- Base Year: 6,297 BTL
- Option Year 1: 6,297 BTL
- Option Year 2: 6,297 BTL
- Option Year 3: 6,297 BTL
- Option Year 4: 6,297 BTL

- Item No. 0002: Metaxalone 800 MG tablet – 500 Count BTL
- Base Year: 2,403 BTL
- Option Year 1: 2,403 BTL
- Option Year 2: 2,403 BTL
- Option Year 3: 2,403 BTL
- Option Year 4: 2,403 BTL.

*Note: The quantities specified in the Schedule are estimates only.

Period of Performance
The contract includes a base year with four option years for continued supply.

Place of Performance
The products will be delivered to designated government facilities as specified in the solicitation.

Overview

Agency
DLA Troop Support - Medical [DoD - DLA]
Response Deadline
Jan. 5, 2026, 3:00 p.m. EST (original: Dec. 7, 2025, 3:00 p.m. EST) Past Due
Posted
Nov. 7, 2025, 9:58 a.m. EST (updated: Dec. 22, 2025, 10:52 a.m. EST)
Set Aside
None
NAICS
325412 - Pharmaceutical Preparation Manufacturing
PSC
6505 - Drugs And Biologicals
Place of Performance
Not Provided
Source
Open
Current SBA Size Standard
1300 Employees
Pricing
Likely Fixed Price
Est. Level of Competition
Average
On 11/7/25 DLA Troop Support - Medical issued Solicitation SPE2D2-26-R-0001 for Metaxalone Tablets due 1/5/26. The opportunity was issued full & open with NAICS 325412 and PSC 6505.
Primary Contact
Name
Jeremy Brown   Profile
Email
jeremy.brown@dla.mil
Phone
(445) 737-5419

Secondary Contact

Name
Jason Wray   Profile
Email
jason.wray@dla.mil
Phone
(445) 737-6304

Documents

Posted documents for Solicitation SPE2D2-26-R-0001

Opportunity Assistant

AI Analysis
AI Generate

Opportunity Lifecycle

Procurement notices related to Solicitation SPE2D2-26-R-0001

Award Notifications

Agency published notification of awards for Solicitation SPE2D2-26-R-0001

Incumbent or Similar Awards

Potential Bidders and Partners

Awardees that have won contracts similar to Solicitation SPE2D2-26-R-0001

Similar Active Opportunities

Open contract opportunities similar to Solicitation SPE2D2-26-R-0001

Experts for Metaxalone Tablets

Recommended subject matter experts available for hire

Additional Details

Source Agency Hierarchy
DEPT OF DEFENSE > DEFENSE LOGISTICS AGENCY (DLA) > TROOP SUPPORT MEDICAL > DLA TROOP SUPPORT
FPDS Organization Code
97AS-SPE2D2
Source Organization Code
500045947
Last Updated
Jan. 7, 2026
Last Updated By
jeremy.brown@dla.mil
Archive Date
Jan. 7, 2026